Current Development of Vaccines for Respiratory Viral Infection
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 31 May 2024 | Viewed by 174
Special Issue Editor
Special Issue Information
Dear Colleagues,
Viral respiratory tract infections constitute a substantial disease burden in the population, particularly among young children and older adults. More than 25 viruses have been linked to respiratory infections, including common respiratory pathogens such as rhinovirus (RV), respiratory syncytial virus (RSV), influenza virus (Flu), human metapneumovirus (hMPV), parainfluenza viruses (PIV) and human coronaviruses (CoVs). This Special Issue of Vaccines focuses on the most recent progress and current vaccine development trends in the field of respiratory viral infection. We invite you to contribute with an original research article, review or perspective on the latest research to highlight novel experimental vaccine candidates, scientific data on supporting vaccine strategies, immune responses elicited by a novel vaccine and concerns and optimisations relating vaccine strategies. This Special Issue emphasises major infectious diseases caused by respiratory viruses, but related topics on co-infections are also welcomed. We look forward to receiving your contributions.
Dr. Ting Shi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
